An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations
一种不依赖于BRCA突变的、针对乳腺癌和卵巢癌的有效表观遗传-PARP抑制剂联合疗法
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-18-0204
Pulliam, Nicholas; Fang, Fang; Ozes, Ali R; Tang, Jessica; Adewuyi, Adeoluwa; Keer, Harold; Lyons, John; Baylin, Stephen B; Matei, Daniela; Nakshatri, Harikrishna; Rassool, Feyruz V; Miller, Kathy D; Nephew, Kenneth P
